Exclusive Summary

• The product holds US-FDA GMP certification and is registered in the US, ensuring high product quality and broad international market access, particularly attractive in emerging markets.
• As a broad-spectrum MRI contrast agent, it has extensive applications in neurological, vascular, and oncological diagnostics, driven by high disease prevalence and diagnostic demand, indicating significant market potential.
• The diverse dosage forms (2ml-65ml) meet various clinical scenarios and patient needs, enhancing market competitiveness and flexibility.
• Its status as a generic drug, coupled with cost advantages, presents a strong potential for replacing originator drugs in regions with limited healthcare budgets, enabling rapid market penetration.